The proposed budget released Monday would have winners and losers in Medicare; President Donald Trump's budget, a messaging statement, contains healthcare cuts; veterans in California risk eviction from veterans homes if they intend to use an aid-in-dying law.
President Trump’s budget plan would help some Medicare beneficiaries more than others, the Associated Press reported. About a million beneficiaries with the highest prescription drug costs, whose individual bills reach a total of more than $8418 apiece, will come out on top. But about 4.5 million seniors whose total bills range between $3750 and $8418 could end up spending about $1000 more, because the budget proposes a change in how Medicare accounts for manufacturer discounts received by those patients.
The White House fiscal 2019 budget is largely considered a messaging document with no chance of passage, coming as Congress moves ahead with its own spending plan, The New York Times reported. However, the budget proposes again to “repeal and replace” the Affordable Care Act and to eliminate the law’s expansion of Medicaid. More than 30 states have already expanded Medicaid and GOP efforts to end the law failed in last year. The budget also proposes cuts of $69.5 billion over 10 years in projected Medicare payments to hospitals for “uncompensated care”; more than $95 billion over 10 years from nursing homes and home health agencies; $22 billion from Medicare Advantage plans; and $48 billion over 10 years in Medicare payments to teaching hospitals for graduate medical education.
A controversy is brewing in California where the law that allows terminally ill people to take lethal drugs to end their lives is running into conflict with a regulation that bars residents in veterans homes from using it, Kaiser Health News reported. Advocates of medical aid-in-dying and residents of the Veterans Home of California-Yountville are protesting the regulation from the California Department of Veterans Affairs that requires that anyone living in the facilities to be discharged if they intend to use the law.
What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact
December 8th 2023The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen